Efficacy and safety of granulocyte colony-stimulating factor (IOR®-leukocim) in oncohematology patients. Phase IV

Authors
Category Primary study
JournalVacciMonitor
Year 2010
This article has no abstract
Epistemonikos ID: d20a8f01f3b3c1f9892b176a25bde705fbd5736a
First added on: Feb 07, 2025